Welcome to our dedicated page for Bwx Technologies SEC filings (Ticker: BWXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BWX Technologies, Inc. (NYSE: BWXT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. BWXT files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K that cover financial performance, material agreements, capital structure changes and governance matters related to its nuclear-focused manufacturing and engineering business.
BWXT’s Form 8-K filings illustrate the range of topics investors can track. Recent 8-Ks have reported quarterly financial results, including revenue and segment performance for Government Operations and Commercial Operations, and have furnished earnings press releases that explain non-GAAP measures such as adjusted EBITDA, non-GAAP earnings per share and free cash flow. Other 8-Ks describe executive leadership changes, such as appointments of senior finance and legal officers, and provide details on material definitive agreements.
Filings also document capital markets transactions. In 2025, BWXT filed an 8-K describing the issuance of 0% Convertible Senior Notes due 2030 under an indenture with a trustee, including the aggregate principal amount, guarantee structure by certain domestic subsidiaries, conversion conditions, maturity date and events of default. Another 8-K discusses the planned private offering of convertible senior notes and expectations regarding a new senior secured revolving credit facility, subject to market conditions and other factors.
Through this page, users can follow BWXT’s official disclosures about its nuclear-related operations, contracts and financial condition. Stock Titan enhances access to these documents with AI-powered summaries that highlight key terms in filings such as 10-K and 10-Q reports, and can help interpret complex sections on topics like segment performance, non-GAAP metrics, convertible notes and covenant structures. The page also links to insider and governance-related information reported in current reports, giving a consolidated view of BWXT’s regulatory record.
BWX Technologies announced that Ronald O. Whitford, Jr., Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary, stepped down from these roles and as an executive officer effective November 4, 2025. The company stated his decision is not related to any legal issue or any disagreement with BWXT’s operations, policies or practices.
Whitford will remain employed as Special Advisor to the CEO during a transition period, and BWXT expects to appoint a successor within the coming week. During the transition, he is expected to receive his base salary and is entitled to benefits consistent with a termination without cause under BWXT’s Executive Severance Plan, as described in the company’s March 19, 2025 proxy statement. The announcement outlines continuity measures while the company completes the leadership handoff.
BWX Technologies reported stronger Q3 results, with revenue of $866.3 million up from $672.0 million and diluted EPS of $0.89 versus $0.76 a year ago. Operating income rose to $113.3 million, supported by higher activity in both Government and Commercial Operations.
Year to date, revenue reached $2.31 billion and diluted EPS was $2.57. Operating cash flow for the nine months was a solid $352.9 million, offset by investing cash outflows of $673.9 million primarily for acquisitions. The company closed the Aerojet Ordnance Tennessee purchase for about $101.1 million and acquired Kinectrics for $441.4 million (U.S. dollar equivalent), expanding lifecycle services and isotope capabilities.
Total assets increased to $3.78 billion, with long‑term debt at $1.50 billion and total equity at $1.24 billion. Remaining performance obligations were $7,389.1 million, with about 35% expected to be recognized by the end of 2026. The quarter included favorable cumulative adjustments, and Commercial Operations growth reflects added Canadian non‑government revenue.
BWX Technologies furnished a Form 8‑K under Item 2.02 announcing its financial results for the third quarter ended September 30, 2025, and made available an earnings press release as Exhibit 99.1.
The company states the Item 2.02 information, including Exhibit 99.1, is furnished and not filed under the Exchange Act, is not subject to Section 18 liabilities, and is incorporated by reference only if specifically referenced in future filings.
BWX Technologies (BWXT) insider filing: On 10/24/2025, the company’s VP & Chief Accounting Officer reported the vesting and settlement of 1,795 RSUs into common stock at an exercise price of $0 (coded “M”). To cover taxes, 719 shares were withheld (coded “F”) at $199.92 per share. Following these transactions, the reporting person directly owned 3,618 common shares.
The RSUs vest in three equal annual installments beginning October 24, 2023, and the derivative balance for this RSU grant is now shown as 0.
Nicole W. Piasecki, a director of BWX Technologies, Inc. (BWXT), reported a Form 4 filing related to dividend equivalent rights on restricted stock units. The Form 4 shows a transaction dated 09/05/2025 in which dividend equivalent rights (DERs) were recorded as acquired (code A) representing 5.74 underlying shares of common stock at a $0 price. The filing states these DERs accrued on three restricted stock unit grants for which the reporting person elected to defer receipt; each RSU and DER is a contingent right to receive one share and the DERs will be delivered proportionately with the related RSUs. The report indicates 36.53 shares of common stock beneficially owned following the transaction. The Form 4 is signed by an attorney-in-fact on behalf of Ms. Piasecki on 09/08/2025.
Jan A. Bertsch, a director of BWX Technologies, Inc. (BWXT), reported a transaction dated 09/05/2025 in which 36 dividend equivalent rights (DERs) tied to deferred restricted stock units (RSUs) were acquired. Each DER and RSU represents a contingent right to one share of BWXT common stock and the DERs have a reported price of $0. Following the reported transaction the filing shows 2,142.67 shares beneficially owned. The DERs relate to eight RSU grants for which the reporting person elected deferral; the DERs will be delivered proportionately with the underlying RSUs. The Form 4 is signed on behalf of Mr. Bertsch by an attorney-in-fact on 09/08/2025.
Gerhard F. Burbach, a director of BWX Technologies, Inc. (BWXT), reported a Section 16 transaction dated 09/05/2025. The filing shows the accrual and acquisition of 19.4 dividend equivalent rights related to six restricted stock unit (RSU) grants for which the reporting person elected to defer receipt of the underlying shares. Each RSU and dividend equivalent right (DER) represents a contingent right to one share of BWXT common stock. The DERs have a reported price of $0 and, per the deferral election, will be delivered proportionately with the related RSUs. The filing lists 723.65 shares as the amount beneficially owned following the reported transaction. The form is signed on behalf of Mr. Burbach by an attorney-in-fact.
John M. Richardson, a director of BWX Technologies, Inc. (BWXT), filed a Form 4 disclosing a transaction dated 09/05/2025. The filing reports the acquisition of dividend equivalent rights (DERs) that accrued on four restricted stock unit (RSU) grants for which the reporting person elected to defer receipt of the underlying shares. Each RSU and each DER is described in the filing as a contingent right to receive one share of BWXT common stock. The reported transaction shows a price of $0 and indicates 300 shares beneficially owned following the transaction (ownership listed as direct). The Form 4 is signed on behalf of Mr. Richardson by an attorney-in-fact on 09/08/2025.
Insider Form 4 summary for BWXT
Director Leland D. Melvin (reported as "Melvin Leland D") reported a transaction dated 09/05/2025 reflecting the acquisition of 12.51 dividend equivalent rights (DERs) tied to four restricted stock unit (RSU) grants. Each DER and each RSU represent a contingent right to one share of BWXT common stock and, per Mr. Melvin's deferral election, the DERs will be delivered proportionately with the underlying RSUs. After this reported transaction the filing shows 192.97 shares beneficially owned in direct form. The Form 4 was signed by an attorney-in-fact on 09/08/2025.
James M. Jaska, a director of BWX Technologies (BWXT), recorded a transaction dated 09/05/2025 reflecting dividend equivalent rights (DERs) accrued on seven restricted stock units (RSUs) for which he elected to defer receipt. Each RSU and associated DER represent a contingent right to one share of BWXT common stock. The DERs will be delivered proportionately with the underlying RSUs. The filing shows an acquisition of 23.91 dividend equivalent rights and reports 1,043.71 shares beneficially owned by the reporting person following the transaction. The transaction price is reported as $0, consistent with dividend-equivalent crediting rather than a cash purchase.